CER priorities = awesome
Wednesday, July 1 2009
The Institutes of Medicine just published its list of 100 priorities (.pdf) for comparative effectiveness research, the result of a process that began earlier this year with an online questionnaire and public hearings.
Among the top 25 items – ie, the highest priority – were the following:
- Compare the effectiveness of dissemination and translation techniques to facilitate the use of CER by patients, clinicians, payers, and others.
- Compare the effectiveness of comprehensive care coordination programs, such as the medical home, and usual care in managing children and adults with severe chronic disease, especially in populations with known health disparities.
- Compare the effectiveness of different strategies of introducing biologics into the treatment algorithm for inflammatory diseases, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and psoriatic arthritis.
It’s like they read my mind – but they didn’t have to, because I filled out the questionnaire and suggested all three of these. I’m sure several other people made similar suggestions, too – so it wasn’t all me. But still, it’s good to see that they’re going to spend some of the $1.1 billion for CER on questions that I want to know the answers to.
